We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
VAS
526
Vestmark Advisory Solutions
Massachusetts
$5.4M +$1.01M +9,761 +21%
OAC
527
OMERS Administration Corp
Ontario, Canada
$5.39M
BCM
528
Bayesian Capital Management
New York
$5.39M +$5.72M +55,200 New
Parallax Volatility Advisers
529
Parallax Volatility Advisers
California
$5.39M -$1.5M -14,531 -21%
FCM
530
Fieldview Capital Management
Michigan
$5.34M +$5.67M +54,715 New
SPIA
531
Steward Partners Investment Advisory
New York
$5.33M +$486K +4,696 +9%
VI
532
Vestcor Inc
New Brunswick, Canada
$5.31M -$324K -3,130 -5%
AC
533
Allstate Corporation
Illinois
$5.31M +$5.26M +50,829 +1,433%
CPCPP
534
Canada Post Corporation Pension Plan
Canada
$5.26M +$824K +7,960 +17%
HCMT
535
Highland Capital Management (Tennessee)
Tennessee
$5.22M -$58K -560 -1%
HAG
536
HighPoint Advisor Group
Illinois
$5.22M +$258K +2,495 +5%
LFM
537
LGT Fund Management
Liechtenstein
$5.2M +$187K +1,808 +3%
SI
538
Sava Infond
Slovenia
$5.17M -$98.4K -950 -2%
VanEck Associates
539
VanEck Associates
New York
$5.16M +$244K +2,360 +5%
TCM
540
Tandem Capital Management
New Jersey
$5.15M -$29.4K -284 -0.5%
FTWA
541
Fifth Third Wealth Advisors
Ohio
$5.12M +$137K +1,323 +3%
MC
542
Machina Capital
France
$5.1M +$2.94M +28,401 +119%
TA
543
TKG Advisors
Indiana
$5.08M +$43.4K +419 +0.8%
GIA
544
Gladstone Institutional Advisory
Florida
$5.07M +$1.52M +14,700 +40%
PAS
545
Park Avenue Securities
New York
$5.05M +$223K +2,150 +4%
PIM
546
Penobscot Investment Management
Massachusetts
$5.04M +$938K +9,053 +21%
UCFA
547
United Capital Financial Advisors
Texas
$5.03M +$827K +7,990 +18%
CPC
548
Consolidated Planning Corp
Georgia
$4.94M +$29.5K +285 +0.6%
EF
549
Empirical Finance
Pennsylvania
$4.94M +$53.5K +517 +1%
ECM
550
Everence Capital Management
Indiana
$4.93M

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.